(Q59340052)

Katie Biggs

12

0 references

Franz König

Franz Koenig

10

0 references

Philip Pallmann

Philip Pallmann

3

0 references

James Wason

James Wason

7

0 references

Douglas G. Altman

19

Douglas G Altman

0 references

author name string

Elizabeth Coates

2

0 references

Susan Todd

4

0 references

Steven A Julious

5

0 references

Thomas Jaki

6

0 references

Adrian P Mander

8

0 references

Christopher J Weir

9

0 references

Marc K Walton

11

0 references

Jon Nicholl

13

0 references

Toshimitsu Hamasaki

14

0 references

Michael A Proschan

15

0 references

John A Scott

16

0 references

Yuki Ando

17

0 references

Daniel Hind

Creative Commons Attribution 4.0 International

18

0 references

language of work or name

English

0 references

publication date

16 November 2018

0 references

published in

BMC Medicine

0 references

volume

16

0 references

issue

1

0 references

page(s)

210

0 references

copyright license

start time

16 November 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s12916-018-1196-2

0 references

cites work

The Measurement of Observer Agreement for Categorical Data

1 reference

12 December 2020

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

12 December 2020

The advantages and disadvantages of adaptive designs for clinical trials

1 reference

12 December 2020

Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group

1 reference

12 December 2020

Application of adaptive designs--a review

1 reference

12 December 2020

FDA's critical path initiative: a perspective on contributions of biostatistics

1 reference

12 December 2020

Confirmatory clinical trials with an adaptive design

1 reference

12 December 2020

How practical are adaptive designs likely to be for confirmatory trials?

1 reference

12 December 2020

Operational challenges in adaptive design implementation

1 reference

12 December 2020

Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group.

1 reference

12 December 2020

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration

1 reference

12 December 2020

CONSORT for reporting randomised trials in journal and conference abstracts

1 reference

12 December 2020

Adaptive design methods in clinical trials - a review

1 reference

12 December 2020

Adaptive clinical trials: progress and challenges

1 reference

12 December 2020

Adaptive designs for confirmatory clinical trials

1 reference

12 December 2020

Adaptive designs for randomized trials in public health

1 reference

12 December 2020

Guidance for developers of health research reporting guidelines

1 reference

12 December 2020

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

1 reference

12 December 2020

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

1 reference

12 December 2020

Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development

1 reference

12 December 2020

Adaptive design clinical trials and trial logistics models in CNS drug development

1 reference

12 December 2020

Review of draft FDA adaptive design guidance

1 reference

12 December 2020

FDA draft guidance on adaptive design clinical trials: Pfizer's perspective

1 reference

12 December 2020

Adaptive methods: when and how should they be used in clinical trials?

1 reference

12 December 2020

Benefits, challenges and obstacles of adaptive clinical trial designs

1 reference

12 December 2020

Adaptive trial designs: a review of barriers and opportunities

1 reference

12 December 2020

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop

1 reference

12 December 2020

Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study

1 reference

12 December 2020

Uptake of novel statistical methods for early-phase clinical studies in the UK public sector

1 reference

12 December 2020

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

1 reference

12 December 2020

The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development

1 reference

12 December 2020

Adaptive clinical trial design

1 reference

12 December 2020

Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies.

1 reference

12 December 2020

Three steps to writing adaptive study protocols in the early phase clinical development of new medicines

1 reference

12 December 2020

Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency

1 reference

12 December 2020

Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

1 reference

12 December 2020

CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement

1 reference

12 December 2020

COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).

1 reference

12 December 2020

Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials

1 reference

12 December 2020

An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review

1 reference

12 December 2020

Reflections on the Adaptive Designs Accelerating Promising Trials Into Treatments (ADAPT-IT) Process-Findings from a Qualitative Study

1 reference

12 December 2020

Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials

1 reference

12 December 2020

Adaptive designs undertaken in clinical research: a review of registered clinical trials

1 reference

12 December 2020

Estimands: discussion points from the PSI estimands and sensitivity expert group

1 reference

12 December 2020

Adaptive Clinical Trial Design: An Overview and Potential Applications in Dermatology

1 reference

12 December 2020

Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement.

1 reference

12 December 2020

Estimands in clinical trials - broadening the perspective

1 reference

12 December 2020

Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project

1 reference

12 December 2020

Preferred reporting of case series in surgery; the PROCESS guidelines

1 reference

12 December 2020

CONSORT 2010 statement: extension to randomised pilot and feasibility trials

1 reference

12 December 2020

CONSORT 2010 statement: extension to randomised pilot and feasibility trials

1 reference

12 December 2020

The role of adaptive trial designs in drug development

1 reference

12 December 2020

Efficient design of clinical trials and epidemiological research: is it possible?

1 reference

12 December 2020

Embracing model-based designs for dose-finding trials.

1 reference

12 December 2020

A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines

1 reference

12 December 2020

Practical characteristics of adaptive design in phase 2 and 3 clinical trials.

1 reference

12 December 2020

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.

1 reference

12 December 2020

Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?

1 reference

12 December 2020

Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov.

1 reference

12 December 2020

Adaptive designs in clinical trials: why use them, and how to run and report them.

1 reference

12 December 2020

Key design considerations for adaptive clinical trials: a primer for clinicians.

1 reference

12 December 2020

Critical concepts in adaptive clinical trials.

1 reference

12 December 2020

CBER’s Experience With Adaptive Design Clinical Trials

1 reference

12 December 2020

Adaptive Clinical Trials: Overview of Phase III Designs and Challenges

1 reference

12 December 2020

Adaptive Design Practice at the Center for Devices and Radiological Health (CDRH), January 2007 to May 2013

1 reference

12 December 2020

Adaptive Design: Results of 2012 Survey on Perception and Use

1 reference

12 December 2020